Finally, a detailed knowledge of the signaling pathway that modulates hepcidin expression should inform a new pharmacologic approach to modifying brain iron homeostasis, offering new treatment modalities of pediatric AIS. The gene discussed is HAMP; the disease is androgen insensitivity syndrome.